Literature DB >> 17704900

[A 64-year-old female patient with recurring hypoglycaemia. Difficult aspects of diagnosis].

W Hunger-Dathe1, M Hocke, A Sämann, U A Müller, G Wolf, M Gajda.   

Abstract

Insulinomas are the most common pancreatic islet cell tumours and are characterised by uncontrolled insulin secretion even in the presence of hypoglycaemia. Diagnosis is usually made by the detection of endogenous hyperinsulinism over a period of fasting. We report the case of a patient with insulinoma without hyperinsulinaemia. A secretion and overexpression of split insulin has to be discussed. The diagnosis was made by endoscopic ultrasound-guided fine-needle aspiration and the immunohistochemical detection of chromogranine. In conclusion, the present report demonstrates that insulinomas should be considered and searched for in every case of hypoglycaemia, even when associated with normal insulin levels. It also confirms the essential role of endoscopic ultrasonography in the diagnosis of insulin-secreting tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17704900     DOI: 10.1007/s00108-007-1924-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  22 in total

1.  Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.

Authors:  Jens Rosenau; Matthias J Bahr; Reinhard von Wasielewski; Michael Mengel; Hartmut H J Schmidt; Björn Nashan; Hauke Lang; Jürgen Klempnauer; Michael P Manns; Klaus H W Boeker
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

Review 2.  Surgical aspects of hyperinsulinemic hypoglycemia.

Authors:  C S Grant
Journal:  Endocrinol Metab Clin North Am       Date:  1999-09       Impact factor: 4.741

Review 3.  Multiple endocrine neoplasia.

Authors:  R V Thakker
Journal:  Horm Res       Date:  2001

Review 4.  Endocrine tumours of the pancreas: review and recent advances.

Authors:  M H Mullan; P G Gauger; N W Thompson
Journal:  ANZ J Surg       Date:  2001-08       Impact factor: 1.872

Review 5.  [Diagnostic and therapeutic difficulties in MEN 1 syndrome].

Authors:  Janusz Krassowski
Journal:  Endokrynol Pol       Date:  2005 May-Jun       Impact factor: 1.582

6.  Laparoscopic approach for solitary insulinoma: a multicentre study.

Authors:  A Ayav; L Bresler; L Brunaud; P Boissel
Journal:  Langenbecks Arch Surg       Date:  2004-12-18       Impact factor: 3.445

7.  p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior.

Authors:  G Canavese; C Azzoni; S Pizzi; V D Corleto; C Pasquali; C Davoli; P Crafa; G Delle Fave; C Bordi
Journal:  Hum Pathol       Date:  2001-10       Impact factor: 3.466

8.  [Diagnosis and surgical treatment of insulinoma--experiences in 40 cases].

Authors:  V Fendrich; D K Bartsch; P Langer; A Zielke; M Rothmund
Journal:  Dtsch Med Wochenschr       Date:  2004-04-23       Impact factor: 0.628

9.  Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.

Authors:  D Nehar; C Lombard-Bohas; S Olivieri; B Claustrat; J-A Chayvialle; M-C Penes; G Sassolas; F Borson-Chazot
Journal:  Clin Endocrinol (Oxf)       Date:  2004-05       Impact factor: 3.478

10.  Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.

Authors:  E Baudin; A Gigliotti; M Ducreux; J Ropers; E Comoy; J C Sabourin; J M Bidart; A F Cailleux; R Bonacci; P Ruffié; M Schlumberger
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

View more
  1 in total

1.  Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patients.

Authors:  Peter Herbert Kann; Roland Moll; Detlef Bartsch; Andreas Pfützner; Thomas Forst; Gianluca Tamagno; Joachim N Goebel; Verena Fourkiotis; Simona Raluca Bergmann; Maike Collienne
Journal:  Endocrine       Date:  2016-11-30       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.